Innospec | IOSP - Sales Revenues


Innospec reported $453.2M in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
Akzo Nobel EUR 2.39B 20M Mar/2026
Arkema EUR 2.18B 70M Mar/2026
Arq USD 29.43M 5.64M Dec/2025
Ashland USD 482M 96M Mar/2026
Avient USD 847M 86M Mar/2026
Balchem USD 270.7M 7.08M Mar/2026
BASF EUR 16.02B 1.99B Mar/2026
Croda International GBP 825.73M 412.23M Dec/2025
Evogene USD 314K 2K Dec/2025
Flotek Industries USD 70.05M 20.31M Mar/2026
FutureFuel USD 19.84M 31.3M Dec/2025
HB Fuller USD 894.79M 2.74M Sep/2025
Huntsman USD 1.42B 60M Mar/2026
Innospec USD 453.2M 2.4M Mar/2026
Minerals Technologies USD 546.9M 26.9M Mar/2026
NewMarket USD 669.7M 34.3M Mar/2026
Quaker Chemical USD 480.5M 12.02M Mar/2026
Rayonier Advanced Materials USD 319M 98.54M Mar/2026
Sensient Technologies USD 435.8M 42.4M Mar/2026
Solvay EUR 997M 2M Mar/2026
Stepan USD 604.51M 50.62M Mar/2026
Total Nigeria NGN 197.18B 17.13B Mar/2026
Valhi USD 560.1M 65.6M Mar/2026